J A Martínez-Piñeiro

Author

Also Known As

J A Martinez-Piñeiro, J A Martinez-pineiro, J A Martínez-Piñeiro, J Martinez-Pineiro, J. A. MARTINEZ‐PINEIRO, J. A. MARTINEZ‐PIÑEIRO, J. A. MARTÍNEZ‐PIÑEIRO, J. A. Martinez-Pineiro, J. A. Martinez-Piñeiro, J. A. Martínez-Piñeiro

103

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Universidad Autónoma de Madrid Marqués de Valdecilla University Hospital Hospital de Basurto Hospital Clínico San Carlos

About

J A Martínez-Piñeiro is an author at Hospital Universitario La Paz specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	1.2K
2	Health Sciences	1	1	22
3	Public Health	1	1	165
4	Endocrinology	1	1	20
5	Gastroenterology	1	1	10

J A Martínez-Piñeiro

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, The Journal of Urology	2009	639
Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda, European Urology Prognostic FactorsUrologyBacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary Cancer	2007	254
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C Antonio Ojea, José Luís Nogueira, Eduardo Solsona, European Urology UrologySurgical OncologyGenitourinary CancerMedicineVersus Mitomycin C	2007	204
Endourological Treatment of Upper Tract Urothelial Carcinomas: Analysis of a Series of 59 Tumors J A Martínez-Piñeiro, Ma. Justa Garcia Matres, Luis Martínez‐Piñeiro The Journal of Urology	1996	202
HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL J A Martínez-Piñeiro, Luis Martínez‐Piñeiro, Eduardo Solsona, The Journal of Urology	2005	192
The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, European Urology External ValidationSurgical OncologyUrologyCancer EpidemiologyUrologic Cancer Epidemiology	2011	165
Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III Study J A Martínez-Piñeiro, M. González Martín, Fernando Arocena, The Journal of Urology Surgical OncologyAdjuvant ChemotherapySurgeryReconstructive UrologyGynecology Oncology	1995	162
Excision and Anastomotic Repair for Urethral Stricture Disease: Experience with 150 Cases J A Martínez-Piñeiro, Paloma M. Cárcamo, M J García Matres, European Urology UrologyVoiding DysfunctionAnastomotic RepairUrethral Stricture DiseaseSurgery	1997	84
Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013 Luis Martínez‐Piñeiro, José Antonio Portillo, J.M. Fernández Gómez, European Urology Urological ResearchSurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary Cancer	2015	76
Nonspecific Immunotherapy with BCG Vaccine in Bladder Tumors J A Martínez-Piñeiro, Pedro Muntañola European Urology VaccinationTumor ImmunologyUrologyVaccine DevelopmentImmunology	1977	59

Page 1